Skye Bioscience, Inc. Common Stock (SKYE) — Cash Flow Quality Index
Skye Bioscience, Inc. Common Stock (SKYE) has a Cash Flow Quality Index of 0.00x as of December 2025. Operating cash flow of $-9.77 Million is below net income of $11.08 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore debt repayment capacity of Skye Bioscience, Inc. Common Stock to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Skye Bioscience, Inc. Common Stock Cash Flow Quality Index (2012–2019)
Historical Cash Flow Quality Index for Skye Bioscience, Inc. Common Stock across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see SKYE operating cash flow.
Annual Cash Flow Quality Index for Skye Bioscience, Inc. Common Stock (2012–2019)
Year-by-year earnings quality comparison for Skye Bioscience, Inc. Common Stock.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2019 | -5.73x | $-6.03 Million | $1.05 Million | ▼ -1440.3% |
| 2012 | 0.43x | $1.93K | $4.51K | — |